Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Abbott Laboratories shows growth in core products amid market shifts
Economy

Abbott Laboratories shows growth in core products amid market shifts

Last updated: August 11, 2025 9:20 am
Share
Abbott Laboratories shows growth in core products amid market shifts
SHARE

Abbott Laboratories has shown strong performance in the US medical device sector in the first half of 2025, with steady growth in its core product lines. According to GlobalData, a leading data and analytics company, Abbott’s top revenue product lines have maintained consistent average selling prices (ASPs) from 2024 to 2025, indicating resilience to economic pressures such as evolving tariff policies.

While some of Abbott’s high-volume product lines experienced a decline in ASPs in the first half of 2025 compared to the same period last year, the company’s highest-volume products in 2024 saw modest increases in ASPs. This shift in ASPs may be attributed to changing purchasing strategies among US healthcare facilities, possibly influenced by shifting public health priorities and cost considerations.

Abbott reported a strong first half in 2025, with a 14.8% growth in US medical device sales compared to the first half of 2024. Key product lines like MitraClip, Ensite X, and Tactiflex continue to perform well, contributing to Abbott’s success in the US cardiovascular market, where the company holds approximately 18% market share according to GlobalData.

However, Abbott’s US diagnostics segment experienced a slight decline in year-over-year sales in the second quarter of 2025, particularly in point-of-care and rapid diagnostics. This dip in sales can be attributed to reduced demand for Covid-19 testing, which had previously driven high sales volumes. The changing demand landscape in diagnostics may have impacted Abbott’s high-volume sales in this segment.

Overall, Abbott Laboratories remains a strong player in the US medical device sector, with a diverse product portfolio and a resilient market position. The company’s ability to adapt to changing market dynamics and maintain consistent performance in key product lines bodes well for its future growth and success in the industry.

See also  Giorgio Armani Left an Incredible Legacy, as a Special Vintage Sale Shows
TAGGED:AbbottCoreGrowthLaboratoriesmarketProductsshiftsShows
Share This Article
Twitter Email Copy Link Print
Previous Article Scientists re-create a legendary golden fabric from clam waste Scientists re-create a legendary golden fabric from clam waste
Next Article Carjack suspects lead LA cops on wild chase on live TV Carjack suspects lead LA cops on wild chase on live TV
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Colossal’s Top Articles of 2024 — Colossal

These immersive installations are made entirely of bamboo, a sustainable material that is not only…

December 10, 2024

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

The Food and Drug Administration (FDA) has recently provided instructions to Covid vaccine manufacturers regarding…

May 22, 2025

We’re Not Your Pride Publicity Stunt 

In June, as Pride Month rolls around, institutions across the world remember that they have…

June 2, 2025

Mubi Buys Joe Wright’s ‘Mussolini: Son of the Century’

Mubi, the popular streaming platform, has recently acquired the rights to the Joe Wright-directed drama…

May 12, 2025

Rio Tinto chief Jakob Stausholm to step down

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite…

May 22, 2025

You Might Also Like

Alphabet hikes capex again after earnings beat on strong ad, cloud demand
Economy

Alphabet hikes capex again after earnings beat on strong ad, cloud demand

October 31, 2025
What is a merchant bank?
Economy

What is a merchant bank?

October 30, 2025
Fed Cuts Rates by a Quarter Point, as Expected
Economy

Fed Cuts Rates by a Quarter Point, as Expected

October 30, 2025
Fed’s Standing Repo Facility hits record high as policy meeting outcome looms
Economy

Fed’s Standing Repo Facility hits record high as policy meeting outcome looms

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?